MeSH term
Frequency | Condition_Probility | Animals | 7 | 0.0 |
Guanylate Cyclase/*metabolism | 2 | 11.0 |
Humans | 37 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Solubility | 3 | 0.0 |
Vasodilation/drug effects/*physiology | 2 | 28.0 |
Pepsinogens/*analysis | 2 | 100.0 |
Adult | 10 | 0.0 |
Comparative Study | 9 | 0.0 |
English Abstract | 4 | 0.0 |
Female | 15 | 0.0 |
Male | 17 | 0.0 |
Middle Aged | 13 | 0.0 |
Biological Markers/blood | 2 | 0.0 |
Alleles | 3 | 0.0 |
Disease Susceptibility | 2 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
Genotype | 4 | 0.0 |
Helicobacter Infections/*complications | 2 | 18.0 |
*Helicobacter pylori | 3 | 2.0 |
Pepsinogens/*genetics | 8 | 66.0 |
*Polymorphism, Genetic | 6 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Chronic Disease | 2 | 0.0 |
Anti-Ulcer Agents/therapeutic use | 2 | 16.0 |
Antibodies, Bacterial/*blood | 2 | 4.0 |
Gastrins/*blood | 3 | 7.0 |
Pepsinogens/*blood | 4 | 57.0 |
Sensitivity and Specificity | 2 | 0.0 |
Gastrins/blood | 2 | 2.0 |
Amino Acid Sequence | 5 | 0.0 |
Base Sequence | 6 | 0.0 |
Biological Markers | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Rats | 5 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Pepsinogens/*metabolism | 3 | 100.0 |
Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 6 | 5 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Gastric Mucosa/enzymology | 2 | 15.0 |
Absorption | 2 | 1.0 |
Diuresis | 2 | 6.0 |
Kidney/*metabolism | 2 | 1.0 |
Kidney Tubules/metabolism | 2 | 6.0 |
Molecular Weight | 2 | 0.0 |
Glomerular Filtration Rate | 2 | 1.0 |
Biopsy | 2 | 0.0 |
